Dublin, July 10, 2019 (GLOBE NEWSWIRE) -- The "Global Thoracic Surgery Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
Technological advances and new product launches
The global thoracic surgery market is witnessing several technological advancements in both MI surgeries and open procedures.
Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with the benign esophageal disease and early-stage esophageal cancer. Thus, significant advances in devices will fuel the demand for thoracic surgeries, thereby, driving the growth of the market at a CAGR of more than 9% during the forecast period.
Segment Analysis
This thoracic surgery market analysis considers the revenues generated from products such as CRM and cardiac assist devices, heart valve repair and replacement devices, cardiopulmonary devices, heart defect closure devices, and other thoracic surgery devices. The analysis also considers the sales of thoracic surgery in North America, Europe, Asia, and RoW.
In 2018, the CRM and cardiac assist devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of cardiac arrhythmia will play a significant role in the CRM and cardiac assist devices segment to maintain its market position.
Drivers & Restraints
The market report looks at factors such as the increasing prevalence of CVDs and lung diseases, growing awareness initiatives and access to healthcare, and technological advances and new product launches.
However, the high cost of thoracic surgeries and devices, stringent regulations, and shortage of skilled thoracic surgeons may hamper the growth of the thoracic surgery industry over the forecast period.
Increasing number of thoracic surgeries
The demand for thoracic surgeries has increased significantly among patients with severe comorbid conditions. This is mainly due to technological advancements in thoracic surgery devices along with improved experience and confidence of surgeons to operate on high-risk individuals.
Furthermore, the increase recommendations by health organizations promoting the use of these devices are also propelling the demand for thoracic surgery. Thus, the increasing number of thoracic surgeries is identified as a key trend that will impact the growth of the market during the forecast period.
Competitive Landscape
With the presence of few major players, the global thoracic surgery market is concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thoracic surgery providers that include:
- Abbott Laboratories
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- LivaNova
- Medtronic
Also, the thoracic surgery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Key Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- CRM and cardiac assist devices - Market size and forecast 2018-2023
- Heart valve repair and replacement devices - Market size and forecast 2018-2023
- Cardiopulmonary devices - Market size and forecast 2018-2023
- Heart defect closure devices - Market size and forecast 2018-2023
- Other thoracic surgery devices - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- RoW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- Strategic acquisitions
- Increasing number of thoracic surgeries
- Increasing focus on robotic surgeries
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- LivaNova PLC
- Medtronic PLC
For more information about this report visit https://www.researchandmarkets.com/r/6sh62k
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.